{"id":4234,"date":"2023-04-26T09:48:57","date_gmt":"2023-04-26T01:48:57","guid":{"rendered":"https:\/\/regask.com\/?p=4234"},"modified":"2024-11-22T04:44:55","modified_gmt":"2024-11-21T20:44:55","slug":"fda-%e4%bb%a5%e6%82%a3%e8%80%85%e4%b8%ba%e4%b8%ad%e5%bf%83%e7%9a%84%e8%8d%af%e7%89%a9%e7%a0%94%e5%8f%91","status":"publish","type":"post","link":"https:\/\/regask.com\/zh\/fda-patient-centric-drug-development\/","title":{"rendered":"\u7f8e\u56fd FDA\uff1a\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u7814\u53d1\uff1a\u7ed3\u5408\u2026\u2026"},"content":{"rendered":"<div>\n<div><a href=\"https:\/\/www.fda.gov\/\" target=\"_blank\" rel=\"noopener\">\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40<\/a> \u62df\u8bae\u7684\u6307\u5bfc\u8349\u6848\u9898\u4e3a\u201c\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u5f00\u53d1\uff1a\u5c06\u4e34\u5e8a\u7ed3\u679c\u8bc4\u4f30\u7eb3\u5165\u76d1\u7ba1\u51b3\u7b56\u7684\u7ec8\u70b9\u201d\u3002<\/div>\n<div><\/div>\n<div>\n<div>\u8be5\u6307\u5bfc\u6587\u4ef6\u8349\u6848\uff08\u6307\u5bfc 4\uff09\u662f\u56db\u4efd\u7cfb\u5217\u6587\u4ef6\u7684\u4e00\u90e8\u5206\uff0c\u65e8\u5728\u6536\u96c6\u548c\u63d0\u4ea4\u60a3\u8005\u4f53\u9a8c\u6570\u636e\u548c\u5176\u4ed6\u76f8\u5173\u4fe1\u606f\uff0c\u7528\u4e8e\u836f\u54c1\u7684\u5f00\u53d1\u548c\u76d1\u7ba1<\/div>\n<div><\/div>\n<div>\u76ee\u7684\u662f\uff1a<\/div>\n<ul>\n<li>\u66f4\u597d\u5730\u5c06\u4e34\u5e8a\u7ed3\u679c\u8bc4\u4f30\u7eb3\u5165\u76d1\u7ba1\u51b3\u7b56\u7684\u7a33\u5065\u7ec8\u70b9\u4e2d<\/li>\n<li>\u5efa\u8bae\u53ef\u7528\u4e8e\u6536\u96c6\u3001\u5b58\u50a8\u548c\u5206\u6790\u60a3\u8005\u89c6\u89d2\u6570\u636e\u7684\u65b9\u6cd5\u3001\u6807\u51c6\u548c\u6280\u672f<\/li>\n<li>\u63d0\u4f9b\u8d44\u6e90\u6765\u5e2e\u52a9\u63d0\u4ea4\u60a3\u8005\u4f53\u9a8c\u6570\u636e\u3002<\/li>\n<\/ul>\n<div>\u9f13\u52b1\u8d5e\u52a9\u5546\u548c\u5176\u4ed6\u5229\u76ca\u76f8\u5173\u8005\u5728 2023 \u5e74 7 \u6708 5 \u65e5\u4e4b\u524d\u5bf9\u6307\u5bfc\u8349\u6848\u63d0\u4ea4\u7535\u5b50\u6216\u4e66\u9762\u610f\u89c1\u3002<\/div>\n<\/div>\n<div><\/div>\n<\/div>\n<div>\u9700\u8981\u4e86\u89e3\u66f4\u591a\u6709\u5173\u533b\u7597\u5668\u68b0\u6cd5\u89c4\u53d8\u5316\u7684\u4fe1\u606f\u5417\uff1f <a href=\"https:\/\/regask.com\/zh\/%e6%8e%a5%e8%a7%a6\/\" target=\"_blank\" rel=\"noopener\">\u4e0e RegASK \u7684\u4e13\u5bb6\u53d6\u5f97\u8054\u7cfb\u3002<\/a><\/div>\n<div><\/div>\n<a href=\"https:\/\/regask.com\/zh\/%e6%8e%a5%e8%a7%a6\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>\u66f4\u591a\u8be6\u60c5\u8bf7\u8054\u7cfb RegASK<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-incorporating-clinical-outcome-assessments-endpoints-regulatory\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>\u9605\u8bfb\u66f4\u591a<\/span>\n\t<\/a>\n\n<div class=\"row\"  id=\"row-39534483\">\n\n\t<div id=\"col-703376837\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/regask.com\/zh\/%e6%a1%88%e4%be%8b%e7%a0%94%e7%a9%b6-2\/%e8%b5%84%e6%ba%90-%e6%a1%88%e4%be%8b%e7%a0%94%e7%a9%b6-%e5%8c%bb%e7%96%97%e5%99%a8%e6%a2%b0\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>\u9605\u8bfb\u533b\u7597\u5668\u68b0\u884c\u4e1a\u6848\u4f8b\u7814\u7a76<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u7f8e\u56fd FDA \u63d0\u51fa\u4e86\u9898\u4e3a\u201c\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u5f00\u53d1\uff1a\u5c06\u4e34\u5e8a\u7ed3\u679c\u8bc4\u4f30\u7eb3\u5165\u76d1\u7ba1\u51b3\u7b56\u7ec8\u70b9\u201d\u7684\u6307\u5357\u8349\u6848\u3002\u8be5\u6307\u5357\u6587\u4ef6\u8349\u6848\uff08\u6307\u5357 4\uff09\u662f\u56db\u4efd\u7cfb\u5217\u6587\u4ef6\u7684\u4e00\u90e8\u5206\uff0c\u65e8\u5728\u6536\u96c6\u548c\u63d0\u4ea4\u60a3\u8005\u4f53\u9a8c\u6570\u636e\u548c\u5176\u4ed6\u76f8\u5173\u4fe1\u606f\uff0c\u7528\u4e8e\u836f\u54c1\u7684\u5f00\u53d1\u548c\u76d1\u7ba1\u3002\u5176\u76ee\u7684\u662f\u2026\u2026<\/p>","protected":false},"author":39,"featured_media":2976,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39],"tags":[40],"class_list":["post-4234","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-devices-insights","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Prioritizes Patient Voice in Drug Approvals | RegASK<\/title>\n<meta name=\"description\" content=\"The FDA emphasizes patient experience in drug development. Learn how clinical outcome assessments (COAs) shape regulatory decisions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/zh\/fda-\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u7814\u53d1\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA: Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making\" \/>\n<meta property=\"og:description\" content=\"The FDA emphasizes patient experience in drug development. Learn how clinical outcome assessments (COAs) shape regulatory decisions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/zh\/fda-\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u7814\u53d1\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T01:48:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-21T20:44:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png\" \/>\n\t<meta property=\"og:image:width\" content=\"689\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"US FDA: Patient-Focused Drug Development: Incorporating&hellip;\",\"datePublished\":\"2023-04-26T01:48:57+00:00\",\"dateModified\":\"2024-11-21T20:44:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/\"},\"wordCount\":210,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Medical Devices\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/\",\"name\":\"FDA Prioritizes Patient Voice in Drug Approvals | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"datePublished\":\"2023-04-26T01:48:57+00:00\",\"dateModified\":\"2024-11-21T20:44:55+00:00\",\"description\":\"The FDA emphasizes patient experience in drug development. Learn how clinical outcome assessments (COAs) shape regulatory decisions.\",\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-patient-centric-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"width\":689,\"height\":626,\"caption\":\"fda\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA \u5728\u836f\u54c1\u5ba1\u6279\u4e2d\u4f18\u5148\u8003\u8651\u60a3\u8005\u7684\u610f\u89c1 | RegASK","description":"FDA \u5728\u836f\u7269\u7814\u53d1\u4e2d\u91cd\u89c6\u60a3\u8005\u4f53\u9a8c\u3002\u4e86\u89e3\u4e34\u5e8a\u7ed3\u679c\u8bc4\u4f30 (COA) \u5982\u4f55\u5f71\u54cd\u76d1\u7ba1\u51b3\u7b56\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/zh\/fda-\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u7814\u53d1\/","og_locale":"zh_CN","og_type":"article","og_title":"US FDA: Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making","og_description":"The FDA emphasizes patient experience in drug development. Learn how clinical outcome assessments (COAs) shape regulatory decisions.","og_url":"https:\/\/regask.com\/zh\/fda-\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\u7684\u836f\u7269\u7814\u53d1\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2023-04-26T01:48:57+00:00","article_modified_time":"2024-11-21T20:44:55+00:00","og_image":[{"width":689,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u4f5c\u8005":"Benoit Trouwaert","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"US FDA: Patient-Focused Drug Development: Incorporating&hellip;","datePublished":"2023-04-26T01:48:57+00:00","dateModified":"2024-11-21T20:44:55+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/"},"wordCount":210,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","keywords":["Latest Insights"],"articleSection":["Medical Devices"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/","url":"https:\/\/regask.com\/fda-patient-centric-drug-development\/","name":"FDA \u5728\u836f\u54c1\u5ba1\u6279\u4e2d\u4f18\u5148\u8003\u8651\u60a3\u8005\u7684\u610f\u89c1 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","datePublished":"2023-04-26T01:48:57+00:00","dateModified":"2024-11-21T20:44:55+00:00","description":"FDA \u5728\u836f\u7269\u7814\u53d1\u4e2d\u91cd\u89c6\u60a3\u8005\u4f53\u9a8c\u3002\u4e86\u89e3\u4e34\u5e8a\u7ed3\u679c\u8bc4\u4f30 (COA) \u5982\u4f55\u5f71\u54cd\u76d1\u7ba1\u51b3\u7b56\u3002","inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-patient-centric-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/regask.com\/fda-patient-centric-drug-development\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","width":689,"height":626,"caption":"fda"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u52a9\u529b\u66f4\u660e\u667a\u7684\u76d1\u7ba1\u51b3\u7b56","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"\u4f2f\u52aa\u74e6\u00b7\u7279\u9c81\u74e6\u7279"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/4234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/comments?post=4234"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/4234\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media\/2976"}],"wp:attachment":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media?parent=4234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/categories?post=4234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/tags?post=4234"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}